| Lupin Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500257 |
NSE Symbol : LUPIN |
P/E(TTM) : 17.91 |
|
ISIN Demat : INE326A01037 |
Div & Yield% : 0.57 |
EPS(TTM) : 116.81 |
|
Book Value(₹) : 596.04 |
Market Cap(₹Cr) : 95,552.36 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 16,967.50 | 14,666.50 | 11,258.83 | 11,771.67 | 11,055.93 |
| Other Income | 253.39 | 115.51 | 210.02 | 216.99 | 129.09 |
| Stock Adjustments | 38.35 | 15.93 | -120.79 | 242.38 | 81.86 |
| Total Income | 17,259.24 | 14,797.94 | 11,348.06 | 12,231.04 | 11,266.88 |
| EXPENDITURE : | |||||
| Raw Materials | 4,963.57 | 5,041.16 | 4,676.90 | 4,709.64 | 4,264.17 |
| Power and Fuel Cost | 414.63 | 444.41 | 447.42 | 418.45 | 389.54 |
| Other Manufacturing Expenses | 1,268.19 | 1,182.52 | 1,155.60 | 1,209.09 | 1,135.79 |
| Selling and Administration Expenses | 2,349.23 | 2,264.54 | 1,797.13 | 1,573.22 | 1,355.01 |
| Miscellaneous Expenses | 382.24 | 204.01 | 162.95 | 1,976.35 | 253.36 |
| Employee Benefit Expenses | 2,312.07 | 2,095.51 | 1,934.14 | 1,918.16 | 1,695.86 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 5,569.31 | 3,565.79 | 1,173.92 | 426.13 | 2,173.15 |
| Interest | 84.50 | 56.35 | 98.44 | 73.47 | 40.62 |
| Gross Profit | 5,484.81 | 3,509.44 | 1,075.48 | 352.66 | 2,132.53 |
| Depreciation | 647.69 | 724.75 | 548.34 | 514.19 | 502.83 |
| Profit Before Tax | 4,837.12 | 2,784.69 | 527.14 | -161.53 | 1,629.70 |
| Current Tax | 857.12 | 484.05 | 95.89 | 57.80 | 362.85 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 7.04 | -25.45 | 6.04 | -30.63 | 8.23 |
| Reported Net Profit | 3,972.96 | 2,326.09 | 425.21 | -188.70 | 1,258.62 |
| Extraordinary Items | -27.20 | 23.78 | 14.42 | 30.64 | 41.61 |
| Adjusted Net Profit | 4,000.16 | 2,302.31 | 410.79 | -219.34 | 1,217.01 |
| Adjustment below Net Profit | -14.47 | -8.79 | -1.39 | 2.42 | -7.89 |
| Profit/Loss Balance carried down | 17,333.97 | 15,274.71 | 15,032.74 | 15,514.10 | 14,535.25 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 379.01 | 258.04 | 181.85 | 295.08 | 271.88 |
| P & L Balance carried down | 20,913.45 | 17,333.97 | 15,274.71 | 15,032.74 | 15,514.10 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 600.00 | 400.00 | 200.00 | 200.00 | 325.00 |
| Dividend Per Share(Rs) | 12.00 | 8.00 | 4.00 | 4.00 | 6.50 |
| Earnings Per Share-Unit Curr | 87.01 | 51.04 | 9.35 | -4.15 | 27.74 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 531.72 | 452.12 | 404.66 | 399.34 | 409.20 |
| Book Value(Adj)-Unit Curr | 531.72 | 452.12 | 404.66 | 399.34 | 409.20 |